Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trial Management Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global clinical trial management systems market reached a value of US$ 927.4 Million in 2021. Looking forward, the publisher expects the market to reach a value of US$ 1,840.40 Million by 2027 exhibiting a CAGR of 11.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
A clinical trial management system (CTMS) refers to a suite of tools used to effectively plan, track, and manage clinical trials in medical research studies. It includes start-up timelines, monitoring and reporting protocol information and accrual data, financial management and billing compliance, and reporting and business analytics. It also comprises shared study calendars and standardized billing processes, including invoicing and subject visit tracking. Consequently, medical researchers worldwide are relying on CTMS to access transparent and unified critical components of study management and facilitate the transfer of patient data.
Clinical Trial Management Systems Market Trends:
Biotech, pharmaceuticals, and other research-focused life science organizations run complicated clinical trials for developing new medicines and devices that help cure various chronic diseases. In recent years, these clinical trials have become more intricate due to high research and development (R&D) costs, massive data generation, and the incorporation of advanced technologies. Consequently, there is a rise in the demand for CTMS as it serves as a centralized, web-based enterprise resource to support complex clinical research studies in real-time.
Apart from this, the outbreak of coronavirus disease (COVID-19) is positively influencing the need for cloud-based CTMS to conduct clinical trials of medical products, which play a pivotal role in treating critical patients. Moreover, the growing prevalence of new infectious and chronic diseases is augmenting the adoption of advanced diagnostics and drug discovery tools, which, in turn, is acting as another growth-inducing factor. In line with this, the increasing aging population, in confluence with the rising preferences for regenerative medicine and personalized treatment, is contributing to the market growth. Besides this, market players are developing automated CTMS solutions for improving productivity, study reconciliation, and data quality, which is anticipated to create a positive market outlook.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global clinical trial management systems market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on component, deployment mode and end user.
Breakup by Component:
- Software
- Services
Breakup by Deployment Mode:
- Web-based CTMS
- On-premise
- Cloud-based CTMS
Breakup by End User:
- Pharmaceutical and Biotechnology Firms
- Contract Research Organizations
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advarra Inc., ArisGlobal LLC, BioClinica Inc., DataTrak International Inc., DZS Clinical Services Inc. (WDB Holdings Co. Ltd.), International Business Machines Corporation, Medidata Solutions Inc. (Dassault Systemes SE), MedNet Solutions Inc., Oracle Corporation, Parexel International Corporation, RealTime Software Solutions LLC and Veeva Systems Inc.
Key Questions Answered in this Report:
- How has the global clinical trial management systems market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global clinical trial management systems market?
- What are the key regional markets?
- What is the breakup of the market based on the component?
- What is the breakup of the market based on the deployment mode?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global clinical trial management systems market and who are the key players?
- What is the degree of competition in the industry?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Clinical Trial Management Systems Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Software
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Deployment Mode
7.1 Web-based CTMS
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 On-premise
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cloud-based CTMS
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Pharmaceutical and Biotechnology Firms
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Contract Research Organizations
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
10 SWOT Analysis
11 Value Chain Analysis
12 Porters Five Forces Analysis
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Advarra Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 ArisGlobal LLC
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 BioClinica Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.4 DataTrak International Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 DZS Clinical Services Inc. (WDB Holdings Co. Ltd.)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 International Business Machines Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Medidata Solutions Inc. (Dassault Systemes SE)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 MedNet Solutions Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Oracle Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Parexel International Corporation
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 SWOT Analysis
14.3.11 RealTime Software Solutions LLC
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Veeva Systems Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
For more information about this report visit https://www.researchandmarkets.com/r/b1sfaq
Attachment
